MIF is a proinflammatory cytokine (23), that has been implicated in various malignancies, including melanoma, where it contributes to tumor progression and metastasis through its effects on cell proliferation, angiogenesis, and immune evasion (24–26). Here, MIF is linked to neoplasm.